Left Menu
Development News Edition

Australian COVID-19 vaccine candidate produces antibody response in early tests

Early testing of a potential COVID-19 vaccine developed by an Australian university and CSL Ltd has shown it to be safe and produce an antibody response, Minister for Health Greg Hunt said on Friday. Pharmaceutical companies are racing to develop effective treatments for the disease amid a surge in COVID-19 cases that has killed over a million people and battered the world's economy.

Reuters | Updated: 13-11-2020 06:49 IST | Created: 13-11-2020 06:49 IST
Australian COVID-19 vaccine candidate produces antibody response in early tests

Early testing of a potential COVID-19 vaccine developed by an Australian university and CSL Ltd has shown it to be safe and produce an antibody response, Minister for Health Greg Hunt said on Friday.

Pharmaceutical companies are racing to develop effective treatments for the disease amid a surge in COVID-19 cases that has killed over a million people and battered the world's economy. Several candidates including ones produced Pfizer Inc and AstraZeneca are expected to imminently announce the results from last stage testing.

Pfizer said earlier this week that its experimental COVID-19 vaccine had been more than 90% effective based on initial trial results. While slightly behind other candidates, the vaccine candidate developed by the University of Queensland and CSL will now begin the last stage of testing, Hunt said.

"The vaccine is proving to be safe through phase I clinical trials and that it is proving to produce a positive antibody response," Hunt told reporters in Queensland. "It is doing its job. That is particularly so in the elderly, and that is an especially important outcome, given the global vulnerability to elderly around the world from COVID-19."

Should it pass those trials, Hunt said it could be ready for distribution by the third quarter of 2021. Australia has already agreed to buy 51 million does of the University of Queensland developed candidate. Australia will also buy the AstraZeneca vaccine too should it pass last stage testing.

(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)


TRENDING

OPINION / BLOG / INTERVIEW

China: A savior for emerging markets or a poison pill?

... ...

Future of Urban Planning: Artificial Intelligence guiding the way

Advances in emerging technologies like Artificial Intelligence and Machine Learning can help us understand our cities better and derive useful insights from real-time data collected through automated models....

Videos

Latest News

Basketball-Philippines cancels hosting of 2021 Asia Cup qualifiers

The Philippines on Tuesday cancelled its hosting of the third round of qualifiers for the 2021 Asia Cup basketball tournament due to tightened travel restrictions aimed at containing COVID-19. The qualifying games had been scheduled for nex...

HK shares close 2.5% lower as stimulus concerns dent risk appetite

Hong Kong shares slumped 2.5 on Tuesday, pulling back sharply from the previous sessions rally, as global investor concerns over the timing of aggressive U.S. stimulus and rising Sino-U.S. tensions whacked risk appetite. The Hang Seng inde...

COVID-19 vaccine supplies continue to be tight, UK minister says

Supplies of COVID-19 vaccine in Britain remain tight, Britains COVID-19 vaccine deployment minister Nadhim Zahawi said on Tuesday, saying he was confident Pfizer, AstraZeneca and Moderna would meet supply commitments. Supplies are tight... ...

German Bund yields hit two-week lows as Italian PM set to resign

Germanys 10-year government bond yield dropped to a two-week low in early trade on Tuesday on political turmoil in Italy and falling Asian stock markets worried about U.S. fiscal stimulus.Italian Prime Minister Giuseppe Conte will hand in h...

Give Feedback